Lxo Drug Patent Portfolio
Lxo owns 2 orange book drugs protected by 16 US patents Given below is the list of Lxo's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10016407 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10149843 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10231961 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10413505 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10420760 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10857095 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10894012 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10933060 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10973811 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US10987347 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US11040032 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US9867815 | Pharmaceutical compositions and methods of using the same | 07 Feb, 2037 | Active |
| US8617595 | Galenic formulations of organic compounds | 19 Aug, 2026 | Active |
| US8617595 | Galenic formulations of organic compounds | 19 Feb, 2026 | Expired |
| US5559111 | δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides | 21 Jan, 2019 | Expired |
| US5559111 | δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides | 21 Jul, 2018 | Expired |
Latest Legal Activities on Lxo's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Lxo.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 4th Year, Large Entity | 03 Jul, 2024 | US10894012 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 22 May, 2024 | US10857095 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 08 Mar, 2023 | US10420760 (Litigated) |
| Payment of Maintenance Fee, 4th Year, Large Entity | 01 Mar, 2023 | US10413505 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 14 Sep, 2022 | US10231961 |
| Payment of Maintenance Fee, 4th Year, Large Entity | 13 Jun, 2022 | US10016407 (Litigated) |
| Surcharge for Late Payment, Large Entity | 13 Jun, 2022 | US10016407 (Litigated) |
| Payment of Maintenance Fee, 4th Year, Large Entity | 09 Jun, 2022 | US10149843 |
|
Maintenance Fee Reminder Mailed
Critical
| 28 Feb, 2022 | US10016407 (Litigated) |
| Surcharge for Late Payment, Large Entity | 14 Jan, 2022 | US9867815 (Litigated) |
| Payment of Maintenance Fee, 4th Year, Large Entity | 14 Jan, 2022 | US9867815 (Litigated) |
|
Maintenance Fee Reminder Mailed
Critical
| 06 Sep, 2021 | US9867815 (Litigated) |
|
Patent Issue Date Used in PTA Calculation
Critical
| 22 Jun, 2021 | US11040032 |
|
Recordation of Patent Grant Mailed
Critical
| 22 Jun, 2021 | US11040032 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 16 Jun, 2021 | US8617595 |
Lxo's Family Patents
Lxo drugs have patent protection in a total of 22 countries. It's US patent count contributes only to 39.6% of its total global patent coverage. 7 countries have all of their patents expired or invalidated which has opened up potential generic launch opportunities in these countries. Click
below to unlock the full patent family tree.
Lxo Drug List
Given below is the complete list of Lxo's drugs and the patents protecting them.
1. Goprelto
Goprelto is protected by 12 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10016407 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(10 years from now)
| Active |
| US10149843 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(10 years from now)
| Active |
| US10231961 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(10 years from now)
| Active |
| US10413505 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(10 years from now)
| Active |
| US10420760 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(10 years from now)
| Active |
| US10857095 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(10 years from now)
| Active |
| US10894012 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(10 years from now)
| Active |
| US10933060 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(10 years from now)
| Active |
| US10973811 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(10 years from now)
| Active |
| US10987347 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(10 years from now)
| Active |
| US11040032 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(10 years from now)
| Active |
| US9867815 | Pharmaceutical compositions and methods of using the same |
07 Feb, 2037
(10 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Goprelto's drug page
2. Tekturna
Tekturna is protected by 4 patents, out of which 3 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8617595
(Pediatric)
| Galenic formulations of organic compounds |
19 Aug, 2026
(5 months from now)
| Active |
| US8617595 | Galenic formulations of organic compounds |
19 Feb, 2026
(4 days ago)
| Expired |
| US5559111
(Pediatric)
| δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides |
21 Jan, 2019
(7 years ago)
| Expired |
| US5559111 | δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides |
21 Jul, 2018
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Tekturna's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List